Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dysgammaglobulinemia characterized by low or undetectable serum levels of immunoglobulin class A (IgA). It is the most common primary antibody deficiency. It may be inherited or the reversible sequela of infection or certain drugs. It may be caused by decreased or inefficient class-switching from progenitor B cells without any corresponding decreases in the other isotypes. Though affected persons may be asymptomatic, low levels of IgA will reduce the immune system's ability to combat infection where IgA is normally secreted, at mucosal surfaces. Selective IgA deficiency is seen in greater proportion among patients with autoimmune disorders.
Biomarker and diagnostic research for selective IgA deficiency disease has been reported in the published literature.
No clinical trials have been registered for selective IgA deficiency disease.
110 publications have been identified in PubMed for selective IgA deficiency disease. Research spans Epidemiology / Natural History (25%), Case Report / Case Series (22%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 28 | 25% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:31 AM UTC
European rare disease database
Patient case studies
24 |
22% |
Laboratory research | 20 | 18% |
Research summaries | 18 | 16% |
Testing and diagnosis research | 11 | 10% |
Clinical study results | 4 | 4% |
Other research | 3 | 3% |
New treatment approaches | 2 | 2% |
Arduin L (2026). [PMID: 41711248](https://pubmed.ncbi.nlm.nih.gov/41711248/). *Transplant infectious disease : an official journal of the Transplantation Society*. [Gene Therapy / Novel Therapeutics]
Killeen RB (2026). [PMID: 30855793](https://pubmed.ncbi.nlm.nih.gov/30855793/). *Unknown Journal*. [Other]
Dargenio VN (2026). [PMID: 42212585](https://pubmed.ncbi.nlm.nih.gov/42212585/). *J Pediatr Gastroenterol Nutr*. [Review / Meta-Analysis]
Wenger TA (2026). [PMID: 42171009](https://pubmed.ncbi.nlm.nih.gov/42171009/). *Otolaryngol Head Neck Surg*. [Epidemiology / Natural History]
Justiz Vaillant AA (2026). [PMID: 29763203](https://pubmed.ncbi.nlm.nih.gov/29763203/). *Unknown Journal*. [Other]
Lecký P (2026). [PMID: 41988554](https://pubmed.ncbi.nlm.nih.gov/41988554/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Foster M (2026). [PMID: 41902543](https://pubmed.ncbi.nlm.nih.gov/41902543/). *Transfusion*. [Diagnostic / Biomarker]
Mathew SK (2026). [PMID: 33232010](https://pubmed.ncbi.nlm.nih.gov/33232010/). *Unknown Journal*. [Other]
McLay B (2026). [PMID: 42051971](https://pubmed.ncbi.nlm.nih.gov/42051971/). *Case Rep Anesthesiol*. [Case Report / Case Series]
Koenen MH (2026). [PMID: 42129858](https://pubmed.ncbi.nlm.nih.gov/42129858/). *Microbiome*. [Basic Science / Preclinical]